Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase
Open Access
- 1 July 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (26), 25196-25201
- https://doi.org/10.1074/jbc.c500175200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Low dose oral cannabinoid therapy reduces progression of atherosclerosis in miceNature, 2005
- Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5′-AMP-activated Protein Kinase KinasePublished by Elsevier ,2005
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelinBritish Journal of Pharmacology, 2004
- AICAR stimulates adiponectin and inhibits cytokines in adipose tissueBiochemical and Biophysical Research Communications, 2004
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKTThe Journal of cell biology, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Pretreatment with Growth Hormone-Releasing Peptide-2 Directly Protects against the Diastolic Dysfunction of Myocardial Stunning in an Isolated, Blood-Perfused Rabbit Heart ModelEndocrinology, 2000
- Growth hormone releasing peptides: A comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cellsLife Sciences, 1997
- Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996